Keratin, Type I Cytoskeletal 9 (KRT9) Antibody,Abbexa,abx033316
KRT9 is the type I keratin 9, an intermediate filament chain expressed only in the terminally differentiated epidermis of palms and soles. Mutations in this protein cause epidermolytic palmoplantar keratoderma.
Host
Rabbit
Reactivity
Human
Application
ELISA, WB, IHC, FCM
Conjugate
Unconjugated
Platform ID
BAB704864935
Abbexa
Contact
Tel: +44 (0) 1223 755950
Fax: +44 (0) 1223 755951
Email:
Product Specifications
Specifications
NameKeratin, Type I Cytoskeletal 9 (KRT9) Antibody
Cat. No.abx033316
Accession NumberP35527
HostRabbit
IsotypeIgG
ReactivityHuman
ConjugationUnconjugated
ApplicationELISA, WB, IHC, FCM
Working DilutionsWB: 1/1000, IHC-P: 1/50 - 1/100, FCM: 1/10 - 1/50. Not tested in IHC-F. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
Molecular WeightCalculated MW: 62.1 kDa
TargetKRT9
ImmunogenKLH-conjugated synthetic peptide between 302-331 amino acids from the Central region of human KRT9.
PurityPurified through a protein A column, followed by peptide affinity purification.
Appearance/FormLiquid
FormulationPBS containing 0.09% sodium azide.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Regulatory StatusResearch Use Only
Category Paths
- Products>Primary Antibodies>IHC Antibodies
- Products>Primary Antibodies>Polyclonal Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.